During the launch of Sebclair Cream in January, Prof Dr Giuseppe Micali, Head of Dermatology Department and Dermatologist Residency Program Director, University of Catania, Italy gave a brief presentation on “Advances In The Management Of Seborrheic Dermatitis”.
Prof Dr Giuseppe Micali informed those present that topical anti-fungals are not very effective when there’s an inflammation of seborrheic dermatitis. In his experience, Sebclair Cream has shown to be effective in mild to moderate seborrheic dermatitis. Having said that, its efficacy on severe forms needs to be better evaluated.
The potential advantages of Sebclair Cream compared to prescription drugs include lower side effects, better tolerability, possibility of prolonged treatment and no age restrictions.
